Valo Therapeutics Announces First Patient Dosed with PeptiCRAd-1 – Innovative Immuno-oncology
Germany based trial of 15 patients with melanoma, triple negative breast cancer or non-small cell…
Germany based trial of 15 patients with melanoma, triple negative breast cancer or non-small cell…
SHANGHAI, China, May 23, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”,…
NMD Pharma initiates Phase I safety, tolerability and pharmacokinetics study of NMD1343 NMD1343 is a…
Data Provides Insight into How Organizations Can Build an AI-Inclusive Culture SAN MATEO, Calif.–(BUSINESS WIRE)–SnapLogic,…
Top Apps AI has released a new tutorial on TinyWow’s writing features. This tutorial unlocks…
MANILA, May 23, 2023 – (ACN Newswire) – The Asia Video Industry Association (AVIA) and…
Visa’s first strategic Tech and Product Hub in Central and Eastern Europe will further expand…
COLUMBUS, Ind.–(BUSINESS WIRE)–Cummins Inc. (NYSE: CMI) today announced it has entered into a definitive agreement…
RESTON, Va.–(BUSINESS WIRE)–#colocation—Transaction Network Services (TNS) is now live within the Nasdaq Nordic colocation data…
New Capabilities Support Mission Critical Coverage, International Spectrum Coordination, and Rogue Base Station Detection BLOOMINGDALE,…
TAIPEI, TW, May 23, 2023 – (ACN Newswire) – The inaugural PowerUP Asia, organized by…
This article or press release has no online content. Please download the associated documents for…
PRINCETON, N.J., May 22, 2023 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile Therapeutics”…
LOS ANGELES–(BUSINESS WIRE)–Faraday Future Intelligent Electric Inc. (Nasdaq: FFIE) (“Faraday Future”, “FF” or “Company”), a…
Seraphic’s First of its Kind Enterprise Browser Security Solution Recognized as Outstanding Best Threat Detection…
Completes Business Combination and Becomes Publicly Traded Company Third Quarter Fiscal 2023 Net Revenues Totaled…
SEATTLE, May 22, 2023 (GLOBE NEWSWIRE) — Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging…
SEATTLE, May 22, 2023 (GLOBE NEWSWIRE) — Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging…
– IVX-A12 induced robust immune responses at Day 28 to both RSV and hMPV in…
– IVX-A12 induced robust immune responses at Day 28 to both RSV and hMPV in…